Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00370383
Status:
COMPLETED
Last Update Posted:
2012-08-07
First Post:
2006-08-30
Brief Title:
A Study Comparing Sequential Satraplatin Erlotinib to Erlotinib in Unresectable Stage 34 Non-small-cell Lung Cancer NSCLC
Sponsor:
Agennix
Organization:
Agennix
Organization Data
Organization:
Agennix
Class:
INDUSTRY
Study ID:
SAT2-05-07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Agennix
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None